Home / Products / Draxxin®(tulathromycin injection) Injectable Solution 50ML

Print page content Print
Increase text size Decrease text size
Text Size

Draxxin®(tulathromycin injection) Injectable Solution 50ML

Draxxin® (tulathromycin injection) Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide.

Expand All
  • Cattle

    Product Description

    Draxxin (tulathromycin injection) is an anti-infective approved for the treatment of bovine respiratory disease (BRD) caused by all four major bacterial pathogens, including Mycoplasma bovis and infectious bovine keratoconjunctivitis (pinkeye) in non-lactating beef and dairy cattle (including calves) and veal calves. Draxxin is also labeled for the treatment of foot rot.

    Indications

    Draxxin is indicated for the following: treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and Mycoplasma bovis; for the treatment of infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis; and for the treatment of interdigital necrobacillosis (bovine foot rot) associated with Fusobacterium necrophorum and Porphyromonas levii.

    Key Benefits

    Draxxin® Injectable Solution can provide effective treatment for:

    • BRD associated with M. haemolytica, P. multocida, H. somni and Mycoplasma bovis
    • Infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis
    • Interdigital necrobacillosis (bovine foot rot) associated with Fusobacterium necrophorum and Porphyromonas levii.

    Draxxin is also indicated for the control of:

    • Respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and Mycoplasma bovis.

    Dosing and Administration

    Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb.) body weight (BW). Do not inject more than 10 mL per injection site.

  • Pork

    Product Description

    Draxxin (tulathromycin injection) is a powerful, fast-acting, single dose swine respiratory disease (SRD) treatment that provides long-lasting protection for improved performance outcomes and reduced mortality in nursery and finishing pigs.1-4

    Also available — Draxxin 25 (tulathromycin injection) designed for nursery pigs.

    The same powerful, long-lasting treatment and protection as Draxxin, but in an optimized concentration formulation, ideal for nursery pig treatment of SRD.

    Indications

    • Draxxin treats and controls complex SRD
    • Draxxin is approved to treat the five major bacterial causes of SRD
      • Actinobacillus pleuropneumoniae
      • Bordetella bronchiseptica
      • Mycoplasma hyopneumoniae
      • Pasteurella multocida
      • Haemophilus (Glaesserella) parasuis
    • Draxxin controls SRD in groups of pigs where SRD has been diagnosed and is associated with:
      • A. pleuropneumoniae
      • M. hyopneumoniae
      • P. multocida

     Key Benefits

    • Fast-acting: Draxxin takes only 15 minutes to achieve maximum concentration in the blood plasma, then quickly travels to the lung and stays at the site of infection at high levels (61 times plasma levels).5
    • Long-lasting: A single dose of Draxxin is clinically proven to provide continuous protection for up to nine days.5

    Dosing and Administration

    To use Draxxin, inject intramuscularly as a single dose in the neck of swine. A single dose is 2.5 mg/kg (1 mL/88 lb.) body weight.

    Swine Dosing Guide for Draxxin Do not inject more than 2.5 mL per injection site.

    Swine Dosing Guide for Draxxin 25

    Do not inject more than 4 mL per injection site.

Important Safety Information

Withdraw Draxxin/Draxxin 25 five (5) days prior to slaughter in swine. Do not use in animals known to be hypersensitive to the product. See full prescribing information for Draxxin and full prescribing information for Draxxin 25.

DRAXXIN has a pre-slaughter withdrawal time of 18 days in cattle. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Draxxin Prescribing Information.

DRAXXIN 25 has a pre-slaughter withdrawal time of 22 days in calves. Do not use in ruminating cattle. Do not use in animals known to be hypersensitive to the product. See full Draxxin 25 Prescribing Information.

 

References

  1. King, D. et al. Effects of Draxxin at weaning in pigs on control of swine respiratory disease including “low” level of PRRS involvement and subsequent performance of pigs. Proceedings of the American Association of Swine Veterinarians Annual Meeting, San Diego 2013.
  2. King, D. et al. Effects of Draxxin at weaning for control of swine respiratory disease in pigs experiencing a natural outbreak. Proceedings of the American Association of Swine Veterinarians Annual Meeting, Dallas 2014.
  3. Sievers, C. et al. Effect of tulathromycin or ceftiofur free acid on post-weaning performance and economic return in porcine reproductive and respiratory syndrome virus infected pigs. Proceedings of the American Association of Swine Veterinarians Annual Meeting, Dallas 2014.
  4. Hocker, J. et al. Effect of tulathromycin on growth and mortality in PRRS-positive weaned pigs. Proceedings of the American Association of Swine Veterinarians Annual Meeting, Indianapolis 2022.
  5. Waag TA, Bradford JR, Lucas MJ, et al. Duration of effectiveness of tulathromycin injectable solution in an Actinobacillus pleuropneumoniae respiratory-disease challenge model in swine. J Swine Health Prod.2008;16(3):126–130.

 

DRX-00355D

Shop Now!

CONTACT US

1-888-963-8471

Mon–Fri, 9am-6:30pm ET

zoetis logo United States flag United States

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2025 Zoetis Services LLC. All rights reserved.